Omnicell (OMCL) Tops Q2 EPS by 8c, Offers Q3 Guidance

Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.31, $0.08 better than the analyst estimate of $0.23. Revenue for the quarter came in at $181.2 million versus the consensus estimate of $174.33 million.

GUIDANCE:

Omnicell sees Q3 2017 EPS of $0.38-$0.45, versus the consensus of $0.46. Omnicell sees Q3 2017 revenue of $188-194 million, versus the consensus of $200.2 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance